Adverse events of six COVID-19 vaccines in patients with autoimmune rheumatic diseases: a cross-sectional study
Author:
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy,Rheumatology
Link
https://link.springer.com/content/pdf/10.1007/s00296-021-05017-9.pdf
Reference18 articles.
1. Johns Hopkins University (2021) COVID-19 dashboard. https://coronavirus.jhu.edu. Accessed 14 Sep 2021.
2. Johns Hopkins University (2021) Coronavirus resource center Mexico. https://coronavirus.jhu.edu/region/mexico. Accessed 14 Sep 2021.
3. da Rosa MR, Francelino Silva Junior LC, Santos Santana FM et al (2021) Clinical manifestations of COVID-19 in the general population: systematic review. Wien Klin Wochenschr 133:377–382. https://doi.org/10.1007/s00508-020-01760-4
4. Gandhi RT, Lynch JB, Del Rio C (2020) Mild or moderate Covid-19. N Engl J Med 383:1757–1766. https://doi.org/10.1056/NEJMcp2009249
5. Mostaghimi D, Valdez CN, Larson HT, Kalinich CC, Iwasaki A (2021) Prevention of host-to-host transmission by SARS-CoV-2 vaccines. Lancet Infect Dis. https://doi.org/10.1016/S1473-3099(21)00472-2
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Antiphospholipid syndrome in the era of COVID-19 – Two sides of a coin;Autoimmunity Reviews;2024-09
2. Safety of CoronaVac and ChAdOx1 vaccines against SARS-CoV-2 in patients with rheumatoid arthritis: data from the Brazilian multicentric study safer;Advances in Rheumatology;2024-08-12
3. Coronavirus disease 2019 vaccination in patients with rheumatic diseases: A bibliometric‐based analysis of trends;Rheumatology & Autoimmunity;2024-06
4. Outcomes of Vaccination Against SARS-CoV-2 in Patients with Rheumatic Diseases in Latvia;Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.;2024-02-01
5. Safety of Coronavac and ChAdOx1 Vaccines Against SARS-CoV-2 in Patients with Rheumatoid Arthritis Data from the Brazilian Multicentric Study Safer;2023-11-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3